Skip to main content

Table 3 Summary of reported ideas of surveillance screening for patients with SDHB mutation

From: Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reports

Refs.

Year

Clinical review (physical examination, BP, PR)

Biochemical test

Imaging test

Age to start surveillance (years)

[4]

2006

Frequency not stated

Annual

MRI or CT from neck to pelvis every 2 years

Consider 18F-DOPA-PET

10

[35]

2014

Every 6–12 months

Annual

MRI or CT from thorax to pelvis every 6–24 months

MRI or CT of skull base and neck every 2–4 years

MIBG scintigraphy every 2–4 years

5–10

[32]

2019

Annual

Annual

MRI of abdomen every year

MRI from skull base to pelvis every 2 years

5

[36]

2019

Annual

Annual

MRI from skull base to pelvis every 2–3 years

5 (10 as to MRI)

[37]

2019

Every 6 months

Annual

Rapid whole-body MRI every 2 years

5 years before the earliest age of onset in the family

  1. BP, blood pressure; PR, pulse rate; MRI, magnetic resonance imaging; CT, computed tomography; MIBG, metaiodobenzylguanidine; 18F-DOPA-PET, 6-[18F]-fluoro-L-3,4-dihydroxyphenylalanine positron emission tomography